| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9678 | 
      | Human Intestinal Absorption | HIA+ | 0.9817 | 
      | Caco-2 Permeability | Caco2- | 0.5194 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7736 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9274 | 
                                                     | Non-inhibitor | 0.9567 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9551 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8149 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8049 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9101 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7798 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9394 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9777 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9614 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9582 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9731 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9924 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9632 | 
                                                                    | Non-inhibitor | 0.9825 | 
      | AMES Toxicity | Non AMES toxic | 0.9424 | 
      | Carcinogens | Carcinogens  | 0.5436 | 
      | Fish Toxicity | High FHMT | 0.5664 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8768 | 
      | Honey Bee Toxicity | High HBT | 0.6970 | 
      | Biodegradation | Ready biodegradable | 0.9425 | 
      | Acute Oral Toxicity | III | 0.8370 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7165 |